Loading company…
Portola Pharmaceuticals develops biopharmaceutical treatments, including anticoagulants for conditions related to thrombosis.
Portola Pharmaceuticals develops therapies for rare diseases, with a focus on anticoagulants and conditions related to thrombosis. Its products are intended for healthcare providers and patients with limited treatment options. Founded in 2003 and based in South San Francisco, the company raised USD 122 mn in its May 2013 IPO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in